Aspen Neuroscience, Inc. ASPE

ASPE Company Overview

Aspen Neuroscience, Inc. is a U.S.-based biotechnology company focused on developing autologous cell therapies for neurodegenerative diseases, particularly Parkinson’s disease. The company operates within the biotechnology, regenerative medicine, and cell therapy industries, with its primary emphasis on induced pluripotent stem cell (iPSC)-based therapeutic development. Aspen’s core strategy centers on generating patient-specific dopaminergic neuron replacement therapies intended to address the underlying neuronal loss associated with Parkinson’s disease rather than only treating symptoms.

The company’s lead development program has focused on personalized regenerative medicine approaches using a patient’s own cells to create replacement neurons for transplantation. Aspen has positioned itself within the emerging field of precision regenerative neurology by combining stem cell biology, cell engineering, and neuroscience-focused clinical development. Publicly available information indicates the company evolved from academic and translational neuroscience research efforts associated with regenerative medicine initiatives in California and later expanded into clinical-stage biotechnology operations.